Ph3Overview /h3 pThe resource, within the Controlling Department, will analyse the efficiency and cost-effectiveness of the operations, through all activities of analysis and verification of cost variances, in order to ensure an adequate and systematic flow of information to the heads of corporate functions. /p h3Responsibilities /h3 ul liReporting and cost control operations monitoring expenditure trends against the budget estimate, identifying any deviations between forecasts and results /li liAnalyzing and recording cost accounting data labour cost, opex and forecasting /li liMonitoring and analysis operating and management costs /li liAnalysis the trend of expense against the budget estimate /li liDrafting budget and forecast reports /li liManaging the approval flow of purchasing requests and periodic analysis of spending progress /li liManaging the approval flow of investments /li /ul h3Skills /h3 ul li5/6 years of experience in similar roles /li liFluency in English language /li liKnowledge of MS Office (especially Excel) /li liAccuracy, planning and organization; problem solving; good analytical skills /li /ul h3Education /h3 pDegree in Economics and related fields /p h3Workplace /h3 pParma /p h3About Us /h3 pFounded in 1825, Bormioli Pharma has been a leading manufacturer of primary packaging for the pharmaceutical industry, offering complete solutions ranging from glass and plastic bottles to plastic and aluminum closures and accessories. As of December 2024, Bormioli Pharma has been fully integrated into the Gerresheimer Group and no longer operates as a standalone brand. Today, its portfolio, expertise, and capabilities continue within Gerresheimer, an innovative systems and solutions provider and a global partner to the pharma, biotech, and cosmetics sectors. The Group offers a comprehensive range of drug containment solutions, closures and accessories, drug delivery systems, medical devices, and health-related solutions. Gerresheimer operates more than 40 production sites across 16 countries in Europe, the Americas, and Asia, and employs approximately 13,600 people worldwide. Discover all of Gerresheimer’s innovative solutions and stay up to date by visiting Gerresheimer’s website and LinkedIn page. /p h3Equal Employment Opportunity /h3 pIn Bormioli Pharma we strongly believe in inclusiveness and diversity as an enrichment factor. /p pFor this reason, Bormioli Pharma does not discriminate in the Recruitment Selection and related placement of personnel on grounds of race, religion, sex (including pregnancy and gender identity), national origin, political affiliation, sexual orientation, marital status, disability, age, family status or other factors not related to merit. /p h3Personnel search and selection agencies /h3 pBormioli Pharma S.p.a. and its Affiliates do not accept unrequested assistance from search and selection companies for employment opportunities. Personnel Selection and Recruitment Agencies and persons represented by an Agency that is not a preferred supplier are not authorized to submit profiles, applications or CVs, nor to forward CVs directly to employees or any other company office, and such submissions will be considered as unsolicited. Any unsolicited CVs, including those sent to the Human Resources Department, will be considered as property of Bormioli Pharma S.p.a.. /p pBormioli Pharma S.p.a. is not responsible for any fees related to unsolicited CVs or applications and explicitly reserves the right to contact candidates submitted with such CVs or applications. No fee will be paid in case of employment of the candidate by Bormioli Pharma S.p.a. and its Affiliates to the Agency with which no pre-existing agreement is in force. /p pIt is permitted to download and/or copy parts of the content of the advertisements related to open positions for personal and non-commercial use only, in particular it is prohibited to i) modify or alter the content in any way and ii) distribute, modify, transmit, reuse, republish or use the text, image and video for public or commercial purposes without prior written authorization obtained from Bormioli Pharma S.p.a.. /p /p #J-18808-Ljbffr